Jesper Østergaard

Jesper Østergaard

Professor


  1. Published

    Oral bioavailability of cinnarizine in dogs: relation to SNEDDS droplet size, drug solubility and in vitro precipitation

    Larsen, A. T., Ohlsson, A. G., Polentarutti, B., Barker, R. A., Phillips, A. R., Abu-Rmaileh, R., Dickinson, P. A., Abrahamsson, B., Østergaard, Jesper & Mullertz, Anette , 2013, In: European Journal of Pharmaceutical Sciences. 48, 1-2, p. 339-50 12 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Published

    Bioavailability of cinnarizine in dogs: effect of SNEDDS loading level and correlation with cinnarizine solubilization during in vitro lipolysis

    Larsen, A. T., Åkesson, P., Juréus, A., Saaby, Lasse, Abu-Rmaileh, R., Abrahamsson, B., Østergaard, Jesper & Mullertz, Anette , Dec 2013, In: Pharmaceutical Research. 30, 12, p. 3101-13 13 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    SNEDDS containing poorly water soluble cinnarizine; development and in Vitro characterization of dispersion, digestion and solubilization

    Larsen, A. T., Ogbonna, A., Abu-Rmaileh, R., Abrahmsson, B., Østergaard, Jesper & Mullertz, Anette , 2012, In: Pharmaceutics. 4, 4, p. 641-665

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    Role of in vitro release models in formulation development and quality control of parenteral depots

    Larsen, C., Larsen, Susan Weng, Yaghmur, Anan, Østergaard, Jesper & Jensen, H., Dec 2009, In: Expert Opinion on Drug Delivery. 6, 12, p. 1283-1295

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    IMIDAZOLE DERIVATIVES AS PRODRUGS OF DICLOFENAC

    Larsen, C. S., Larsen, Susan Weng, Thing, M. A., Kristensen, Jesper Langgaard, JENSEN, H. & Østergaard, Jesper, 6 May 2016, IPC No. A61P 29/ 00 A I, Patent No. WO2016066612, Priority date 28 Oct 2014, Priority No. DK20140070657

    Research output: Patent

  6. Published

    Controlled release - macromolecular prodrugs

    Larsen, C. S., Østergaard, Jesper & Larsen, Susan Weng, 2007, Prodrugs: challenges and rewards. Stella, V. J., Borchardt, R. T., Hageman, M. J., Oliyai, R., Maag, H. & Tilley, J. W. (eds.). New York: Springer, p. 379-416

    Research output: Chapter in Book/Report/Conference proceedingBook chapterResearch

  7. Published

    PRODRUGS OF NON- STEROID ANTI - INFLAMMATORY AGENTS (NSAIDS)

    Larsen, C. S., Larsen, Susan Weng, Thing, M. A., Kristensen, Jesper Langgaard, JENSEN, H. & Østergaard, Jesper, 10 May 2013, IPC No. C07D 487/ 04 A I, Patent No. WO2013064153, Priority date 31 Oct 2011, Priority No. DK20110070591

    Research output: Patent

  8. Published

    Intra-articular depot formulation principles: role in the management of postoperative pain and arthritic disorders

    Larsen, C. S., Østergaard, Jesper, Larsen, Susan Weng, Jensen, H., Jacobsen, Stine, Lindegaard, Casper & Andersen, P. H., 2008, In: Journal of Pharmaceutical Sciences. 97, 11, p. 4622-4654 33 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Published

    PRODRUGS OF NAPROXEN AND DICLOFENAC

    Larsen, C. S., Larsen, Susan Weng, Thing, M. A., Kristensen, Jesper Langgaard, JENSEN, H. & Østergaard, Jesper, 17 Mar 2016, IPC No. A61K 45/ 06 A I, Patent No. US2016074523, Priority date 28 Apr 2014, Priority No. WO2014EP58530

    Research output: Patent

  10. Published

    Role of in vitro release models in formulation development and quality control of parenteral depots

    Larsen, C. S., Larsen, Susan Weng, Jensen, H., Yaghmur, Anan & Østergaard, Jesper, 2009, In: Expert Opinion on Drug Delivery. 6, 12, p. 1283-1295

    Research output: Contribution to journalReviewResearch

Previous 12 3 4 5 6 7 8 9 ...16 Next

ID: 1299275